- Home
- IMNM vs QNST Comparison
IMNM vs QNST Comparison
Compare IMNM & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- QNST
- Stock Information
- Founded
- IMNM 2006
- QNST 1999
- Country
- IMNM United States
- QNST United States
- Employees
- IMNM N/A
- QNST N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- QNST Business Services
- Sector
- IMNM Health Care
- QNST Consumer Discretionary
- Exchange
- IMNM Nasdaq
- QNST Nasdaq
- Market Cap
- IMNM 747.7M
- QNST 870.6M
- IPO Year
- IMNM 2020
- QNST 2010
- Fundamental
- Price
- IMNM $9.91
- QNST $20.31
- Analyst Decision
- IMNM Strong Buy
- QNST Strong Buy
- Analyst Count
- IMNM 5
- QNST 6
- Target Price
- IMNM $28.60
- QNST $28.17
- AVG Volume (30 Days)
- IMNM 695.8K
- QNST 579.6K
- Earning Date
- IMNM 11-13-2024
- QNST 11-04-2024
- Dividend Yield
- IMNM N/A
- QNST N/A
- EPS Growth
- IMNM N/A
- QNST N/A
- EPS
- IMNM N/A
- QNST N/A
- Revenue
- IMNM $10,129,000.00
- QNST $768,810,000.00
- Revenue This Year
- IMNM N/A
- QNST $62.73
- Revenue Next Year
- IMNM N/A
- QNST $8.68
- P/E Ratio
- IMNM N/A
- QNST N/A
- Revenue Growth
- IMNM N/A
- QNST 37.05
- 52 Week Low
- IMNM $6.93
- QNST $10.88
- 52 Week High
- IMNM $30.96
- QNST $26.27
- Technical
- Relative Strength Index (RSI)
- IMNM 30.69
- QNST 48.62
- Support Level
- IMNM $12.46
- QNST $21.76
- Resistance Level
- IMNM $13.52
- QNST $23.48
- Average True Range (ATR)
- IMNM 0.85
- QNST 1.69
- MACD
- IMNM -0.15
- QNST -0.06
- Stochastic Oscillator
- IMNM 6.71
- QNST 21.78
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About QNST QuinStreet Inc.
QuinStreet Inc focuses on serving clients in large, information-intensive industries, where the company has pioneered a broad range of Internet marketing tools. QuintStreet aims to partner with search engine companies by helping build websites with flexible content and offerings that are customizable according to the user base. It generates revenue by delivering measurable online marketing results to the clients. Its product offerings comprise a full range of performance marketing products: Clicks, Inquiries, Calls, Applications, and Full Customer Acquisitions.